• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3 型血管性血友病患者 c.7674-7675insC 突变后导致血管性血友病因子 mRNA 无意义介导衰变。

Nonsense mediated decay of VWF mRNA subsequent to c.7674-7675insC mutation in type3 VWD patients.

机构信息

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

出版信息

Blood Cells Mol Dis. 2012 Jun 15;49(1):48-52. doi: 10.1016/j.bcmd.2012.03.007. Epub 2012 Apr 12.

DOI:10.1016/j.bcmd.2012.03.007
PMID:22503077
Abstract

Von Willebrand disease (VWD), the most common genetic bleeding disorder, is caused by defects in Von Willebrand factor (VWF). Quantitative deficiencies of the protein lead to either VWD type3, the severe form of the disease or VWD type1 with milder clinical manifestation. Null alleles are the most common mutations in VWF gene causing type3. However, some of these mutations are not translated into the protein and are selectively degraded at mRNA level by nonsense-mediated decay (NMD) pathway. Here, we have studied a large VWD type3 pedigree with a premature termination codon (PTC) causing insertion mutation (c.7674-7675insC) in VWF exon 45. We further investigated the impact of the mutation on the VWF mRNA expression using a quantitative Real-time PCR assay and cDNA sequencing. The relative expression of the gene was significantly decreased in the patients' platelets (Mean ratio=0.03 (0.01-0.05), p=0.001) compared to their normal relatives. The heterozygote carriers of the mutation had lower than normal VWF mRNA levels (Mean ratio=0.62 (0.29-0.91), p=0.006). Direct sequencing of exon 45 on the platelet-derived cDNA in the carriers revealed only the wild-type allele confirming the decay of the mutation carrying allele. In conclusion, quantitative analysis of VWF gene expression showed that c.7674-7675insC mutation in VWF gene resulted in degradation of VWF mRNA via NMD. This pathway might play an important role in the pathogenesis of VWD characterized by quantitative deficiency of VWF due to reduced mRNA levels.

摘要

血管性血友病(VWD)是最常见的遗传性出血性疾病,由血管性血友病因子(VWF)缺陷引起。该蛋白的定量缺乏导致 VWD 类型 3,即疾病的严重形式或 VWD 类型 1,临床表现较轻。无义介导的衰变(NMD)途径导致 VWF 基因中的无效等位基因是导致类型 3 的最常见突变。然而,这些突变中的一些没有被翻译为蛋白质,而是在 mRNA 水平上被选择性地降解。在这里,我们研究了一个大型 VWD 类型 3 家系,该家系存在一个导致插入突变(c.7674-7675insC)的提前终止密码子(PTC)在 VWF 外显子 45 中。我们进一步使用定量实时 PCR 检测和 cDNA 测序研究了突变对 VWF mRNA 表达的影响。与正常亲属相比,患者血小板中的基因表达显著降低(平均比值=0.03(0.01-0.05),p=0.001)。该突变的杂合携带者的 VWF mRNA 水平低于正常水平(平均比值=0.62(0.29-0.91),p=0.006)。在携带者的血小板衍生 cDNA 上对外显子 45 进行直接测序仅显示野生型等位基因,证实了携带突变等位基因的降解。总之,VWF 基因表达的定量分析表明,VWF 基因中的 c.7674-7675insC 突变导致 VWF mRNA 通过 NMD 降解。该途径可能在 VWD 的发病机制中起重要作用,VWD 的特征是由于 mRNA 水平降低导致 VWF 的定量缺乏。

相似文献

1
Nonsense mediated decay of VWF mRNA subsequent to c.7674-7675insC mutation in type3 VWD patients.3 型血管性血友病患者 c.7674-7675insC 突变后导致血管性血友病因子 mRNA 无意义介导衰变。
Blood Cells Mol Dis. 2012 Jun 15;49(1):48-52. doi: 10.1016/j.bcmd.2012.03.007. Epub 2012 Apr 12.
2
Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.与不同血管性血友病 (VWD) 类型相关的血管性血友病因子基因中的突变分布在 VWD 患者队列中。
Thromb Haemost. 2012 Oct;108(4):662-71. doi: 10.1160/TH12-02-0089. Epub 2012 Aug 7.
3
Laboratory diagnosis and molecular classification of von Willebrand disease.血管性血友病的实验室诊断与分子分类
Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8.
4
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
5
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.隐性严重1型和3型血管性血友病(VWD)、无症状杂合子携带者与血型O相关的血管性血友病因子缺乏症以及显性1型VWD的特征分析
Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401.
6
Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.2型诺曼底隐性血管性血友病:轻度血友病和1型血管性血友病的可变表现。
Acta Haematol. 2009;121(2-3):119-27. doi: 10.1159/000214852. Epub 2009 Jun 8.
7
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.血管性血友病的特征、分类及治疗:文献与个人经验的批判性评估
Semin Thromb Hemost. 2005 Nov;31(5):577-601. doi: 10.1055/s-2005-922230.
8
Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients.3 型血管性血友病的分子特征、重组蛋白表达和 mRNA 分析:意大利 10 例患者队列研究。
Am J Hematol. 2012 Sep;87(9):870-4. doi: 10.1002/ajh.23265. Epub 2012 Jun 5.
9
Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies.mRNA 加工和稳定性改变作为 von Willebrand 因子定量缺陷的致病机制。
J Thromb Haemost. 2010 Dec;8(12):2736-42. doi: 10.1111/j.1538-7836.2010.04060.x.
10
Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.印度和希腊患者3型血管性血友病的基因缺陷
Blood Cells Mol Dis. 2008 Sep-Oct;41(2):219-22. doi: 10.1016/j.bcmd.2008.03.004. Epub 2008 May 16.

引用本文的文献

1
The current applications of cell-free fetal DNA in prenatal diagnosis of single-gene diseases: A review.游离胎儿DNA在单基因疾病产前诊断中的当前应用:综述
Int J Reprod Biomed. 2022 Sep 6;20(8):613-626. doi: 10.18502/ijrm.v20i8.11751. eCollection 2022 Aug.
2
Molecular Characterization of Iranian Patients with Inherited Coagulation Factor VII Deficiency.伊朗遗传性凝血因子VII缺乏症患者的分子特征分析
Balkan J Med Genet. 2017 Dec 29;20(2):19-26. doi: 10.1515/bjmg-2017-0027. eCollection 2017 Dec.
3
Nonsense-mediated mRNA decay among coagulation factor genes.
凝血因子基因中的无义介导的mRNA降解
Iran J Basic Med Sci. 2016 Apr;19(4):344-9.
4
Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells.顺铂下调胶质母细胞瘤细胞中新型凋亡相关基因 BCL2L12 的表达。
In Vitro Cell Dev Biol Anim. 2013 Jun;49(6):465-72. doi: 10.1007/s11626-013-9622-4. Epub 2013 May 25.